Adhera Therapeutics
(OTC) ATRX
Adhera Therapeutics Financials at a Glance
Market Cap
$700
Revenue (TTM)
$0.00
Net Income (TTM)
$4.49M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-299.19 (Low)
Dividend
$0.00
Beta (Volatility)
-299.19 (Low)
Price
$0.00
Volume
1,182
Open
$0.00
Price
$0.00
Volume
1,182
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
-299.19 (Low)
Price
$0.00
Volume
1,182
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
ATRX News
ATRX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Adhera Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Zahed Subhan, PhD, MBA
Website
www.adherathera.comHeadquarters
Baton Rouge, LA 70820, US
ATRX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
7%
Return on Assets
-27%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$700.00
Shares Outstanding
7.22M
Volume
1.18K
Short Interest
0.00%
Avg. Volume
121.933
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.62M
EBITDA
$0.00
Operating Cash Flow
$1.42M
Capital Expenditure
$0.00
Free Cash Flow
$1.42M
Cash & ST Invst.
$32.00K
Total Debt
$8.59M
Adhera Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$700.00
N/A
Market Cap/Employee
$350.00
N/A
Employees
2
N/A
Net Income
$3.54M
-96.1%
EBITDA
$2.66M
-1548.7%
Quarterly Fundamentals
Net Cash
$10.80M
-37.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$10.09M
+26.2%
Return on Assets
-26.76%
N/A
Return on Invested Capital
7.29%
N/A
Free Cash Flow
$29.16K
+94.9%
Operating Cash Flow
$29.16K
+94.9%